Editorial Archive - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Editorial Archive

The Advantages of LC/MS in Identifying Residual Impurities in Biopharmaceuticals

Fergus Hall, PhD, Section Manager, Pharmaceutical Chemistry at Eurofins BioPharma Product Testing, looks at the complexity of detecting and quantifying residual i...

27 July 2017 Editorial Archive | Labs/Logistics and Cold Chain Supply | Volume 9 Issue 2

Continue Reading →

Editorial Archive

Working with Difficult Preparations – Risks, Regulations, and Considerations

Safety testing is a crucial part of drug development and is dictated by pharmacopoeial guidelines, which must be followed when performing each step of the process...

27 July 2017 Editorial Archive | Labs/Logistics and Cold Chain Supply | Volume 9 Issue 2

Continue Reading →

Editorial Archive

Propelling Holistic Risk Management Using a Next-generation RBM Approach

As the nature of clinical trials grows ever more complex, the requirement for an improved risk-based monitoring (RBM) approach increases. Such an approach improve...

27 July 2017 Editorial Archive | Special Feature | Volume 9 Issue 2

Continue Reading →

Editorial Archive

Will Graph Database Technology Uncover Pharma’s Hidden Insights?

By definition, medical research is about dealing with large quantities of data. That’s even truer in the leading edges of the life sciences, where tackling the th...

27 July 2017 Editorial Archive | Special Feature | Volume 9 Issue 2

Continue Reading →

Clinical Research

HCP Engagement in a Multichannel World: Why Quality Customer Data is Critical

Quality customer data is foundational to commercial operations, and yet most European life sciences companies are not getting what they need from their customer d...

27 July 2017 Clinical Research | Editorial Archive | Volume 9 Issue 2

Continue Reading →

Clinical Research

Technology Assisted Cohort Optimisation of Early-phase Multi-centre Patient Studies

The common aims of early-phase research centre around helping to define the safety, tolerability and pharmacokinetics of a drug at single or multiple doses (or ev...

27 July 2017 Clinical Research | Editorial Archive | Volume 9 Issue 2

Continue Reading →

Clinical Research

Four Easy Steps to Site Optimisation

To Get the Most Out of Investigative Sites, Go After the Low-hanging Fruit In today’s clinical development arena, clinical trial sponsors are expected to achieve...

27 July 2017 Clinical Research | Editorial Archive | Volume 9 Issue 2

Continue Reading →

Drug Discovery, Development and Delivery

Achieving Agility: Real Breakthroughs Belong to the Bold

As the old adage goes, if you keep doing the same things it can’t come as a surprise when the outcome doesn’t improve. Organising data differently offers a way to...

27 July 2017 Drug Discovery, Development and Delivery | Editorial Archive | Volume 9 Issue 2

Continue Reading →

Drug Discovery, Development and Delivery

DSC: A Sensitive Tool for Comparing the Stability of Biosimilars

Growth forecasts for the global biopharmaceuticals market vary, but headline figures of close to USD 300 billion by the year 2021, rising from an estimated value ...

27 July 2017 Drug Discovery, Development and Delivery | Editorial Archive | Volume 9 Issue 2

Continue Reading →

Editorial Archive

Navigation of Key Regulatory Information for Efficient Life-cycle Management of Regulated Product and Application in SINGAPORE

Developing an innovative healthcare product (a drug or a biologic, or a medical device) from the proof-of- concept stage to the marketing stage is an expensive an...

26 July 2017 Editorial Archive | Regulatory & Marketplace | Volume 9 Issue 2

Continue Reading →